KC

Kenneth Chien

North America, United States

Description

Kenneth Chien is the Co-Founder of Moderna Therapeutics.

Investor Profile

Kenneth Chien has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Undisclosed (50%)
  • Series B (50%)

Country Focus

  • Sweden (50%)
  • Belgium (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kenneth Chien frequently co-invest with?

AMF
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Novalis LifeSciences
North America, Virginia, United States, Hampton
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
SP
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
A
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
GP
Europe, Szabolcs-Szatmar-Bereg, Hungary, Nyíregyháza
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1

Which angels does Kenneth Chien often collaborate with?

CK
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1
TV
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1

What are some of recent deals done by Kenneth Chien?

etherna immunotherapies

Niel, Antwerpen, Belgium

etherna develops mRNA and lipid nanoparticle solutions.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series BAug 23, 2022
Amount Raised: $38,869,747
SmartCella

Tullinge, Stockholms Lan, Sweden

SmartCella is a biotechnology company developing cell therapy and delivery devices for cardiac diseases.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
UndisclosedSep 27, 2021
Amount Raised: $37,668,832